Recurrent allelic imbalance at the rat Pten locus in DMBA-induced fibrosarcomas
Related Experiment Video
Updated: Sep 28, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Asa Sjöling1, Emma Samuelson, Tatjana Adamovic
1Department of Cell and Molecular Biology-Genetics, Lundberg Laboratory, Göteborg University, Sweden. Asa.Sjoling@microbio.gu.se
Abstract:
The tumor-suppressor gene PTEN (phosphatase and tensin homolog) is frequently inactivated in different types of human tumors. Less is known about the involvement of the homologous gene Pten in animal model systems of cancer. By sequencing one of the introns of rat Pten, we found an informative intragenic PCR marker suitable for genetic studies. Through use of this marker, the position of Pten in the genetic linkage map was localized to the distal part of rat chromosome 1 (RNO1) by analysis of F2 progeny from an intercross between inbred strains BN and LE. Subsequently, 22 markers from this region (including the intragenic Pten marker) were used to study the occurrence of allelic imbalance in distal RNO1 in fibrosarcomas that had been induced by DMBA in F1(BNxLE) rats. The analysis revealed that allelic imbalance was common in the vicinity of Pten, and there was loss or reduction of one of the Pten alleles in more than 60% of the fibrosarcomas. DNA sequencing was preformed to investigate whether the Pten allele remaining in the tumors was inactivated by mutation. However, no mutations were detected in the genomic sequence of Pten exons 5 to 9 in any of the fibrosarcomas, and normal mRNA transcripts were expressed in all tumors. Thus, based on the targeted selection for loss of Pten observed in some of these tumors and the absence of inactivation of the remaining allele, we suggest that haploinsufficiency of Pten may be an important factor in rat DMBA-induced fibrosarcomas.
Insights
The tumor-suppressor gene Pten (phosphatase and tensin homolog) plays a role in rat fibrosarcomas. Loss of one Pten allele, not mutation, suggests haploinsufficiency contributes to cancer development.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- The tumor-suppressor gene PTEN is frequently inactivated in human cancers.
- The role of the homologous gene Pten in animal cancer models is less understood.
- Investigating Pten's function in rat fibrosarcomas provides insights into cancer mechanisms.
Purpose of the Study:
- To map the Pten gene in the rat genetic linkage map.
- To investigate allelic imbalance of Pten in DMBA-induced rat fibrosarcomas.
- To determine if Pten haploinsufficiency contributes to fibrosarcoma development.
Main Methods:
- Sequencing of rat Pten introns to develop an intragenic PCR marker.
- Genetic mapping using F2 progeny from BN and LE rat strains.
- Analysis of allelic imbalance and DNA sequencing in induced fibrosarcomas.
Main Results:
- Pten was localized to the distal part of rat chromosome 1 (RNO1).
- Allelic imbalance near Pten was observed in over 60% of fibrosarcomas.
- No mutations were detected in Pten exons 5-9, and normal mRNA was expressed.
Conclusions:
- Pten haploinsufficiency is suggested as a significant factor in rat DMBA-induced fibrosarcomas.
- The findings highlight the importance of Pten dosage in cancer development.
- This study establishes a genetic marker for Pten in rats for future research.
Related Concept Videos
Abnormal Proliferation
The Ras Gene
Ras is a superfamily...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

